Literature DB >> 20725544

Changes in skin cancer management : a personal perspective.

Mark Naylor1.   

Abstract

Entities:  

Year:  2010        PMID： 20725544      PMCID： PMC2921748     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


× No keyword cloud information.
  6 in total

Review 1.  Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas.

Authors:  Brian Berman
Journal:  J Drugs Dermatol       Date:  2008-01       Impact factor: 2.114

2.  Basal cell nevus syndrome: a brave new world.

Authors:  Leonard H Goldberg; Bahar F Firoz; Glen J Weiss; Lisa Blaydorn; Gayle Jameson; Daniel D Von Hoff
Journal:  Arch Dermatol       Date:  2010-01

3.  Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.

Authors:  Jean Y Tang; Michelle Aszterbaum; Mohammad Athar; Franco Barsanti; Carol Cappola; Nini Estevez; Jennifer Hebert; Jimmy Hwang; Yefim Khaimskiy; Arianna Kim; Ying Lu; Po-Lin So; Xiuwei Tang; Michael A Kohn; Charles E McCulloch; Levy Kopelovich; David R Bickers; Ervin H Epstein
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

4.  Do postsurgical interventions optimize ultimate scar cosmesis.

Authors:  M H Viera; S Amini; S Konda; B Berman
Journal:  G Ital Dermatol Venereol       Date:  2009-06       Impact factor: 2.011

5.  Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.

Authors:  Darrell S Rigel; Abel M Torres; Haines Ely
Journal:  J Drugs Dermatol       Date:  2008-01       Impact factor: 2.114

6.  A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.

Authors:  Howard W Rogers; Brett M Coldiron
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.